3/17/22 - Module 2: Community Engagement and Representation

March 17, 2022

Community Engagement and Representation will focus upon the importance of open, respectful, and clear communication throughout the community engagement and trial process; practical strategies for implementing and sustaining community and stakeholder engagement; and consideration for the complexity of data that needs to be interoperable, appropriately defined, and representative of diverse communities.

Target Audience

This activity is intended for professionals and staff, leadership, and administration involved in Medical Oncology and Hematology with particular relevance to clinical research. The audience includes investigators, practicing providers, clinical trialists, clinical trials office staff, nurse practitioners, nurses, research nurse specialists, physician assistants, clinical research coordinators, and other frontline staff; Regulatory/IRB committee members, and others with basic experience conducting clinical trials.

Learning Objectives

Upon completion of this activity, participants will be able to:

  1. Consider measures to evaluate progress on community engagement in clinical research.
  2. Build capacity for open, respectful, and clear communication.
  3. Review key principles of community engagement.
  4. Learn practical strategies for implementing and sustaining community engagement and partnership.
  5. Understand the complexity of “data."

Additional Information

Provided by: 

The Multi-Regional Clinical Trials Center of Brigham and Women’s Hospital and Harvard, The Center for Cancer Equity and Engagement at Dana-Farber/Harvard Cancer Center and Mass General Brigham

Please Note:

While attendees are strongly encouraged to attend the live instruction and discussion sessions for each module, attendees may access a pre-recorded version of the instruction session through this learning platform one day before the live instruction and discussion sessions. Each discussion session will also be recorded and posted to this learning platform one day following the live presentation. All recordings will be accessible until one week following the live presentation of Module 6.

For questions or assistance with any special needs regarding the training series, please contact the MRCT Center at:  MRCT@bwh.harvard.edu

Course summary
Available credit: 
  • 1.50 AMA PRA Category 1 Credit™
  • 1.50 Participation
Course opens: 
01/14/2022
Course expires: 
05/13/2022
Event starts: 
03/17/2022 - 4:30pm EDT
Event ends: 
03/17/2022 - 6:00pm EDT
Cost:
$0.00
Part of: 
Equity by Design in Clinical Research: Cancer Trials
Add to calendar: 
Rating: 
0

In support of improving patient care, Mass General Brigham is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Mass General Brigham designates this live activity for a maximum of 1.50  AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Available Credit

  • 1.50 AMA PRA Category 1 Credit™
  • 1.50 Participation

Price

Cost:
$0.00
Please login or register to take this course.

Required Hardware/software

These courses will be run via Zoom. The link to the zoom webinar will be sent to all attendees ahead of the session via email.